Millamolecule

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMillamolecule
Drug Alias NamePD-L1 inhibitor millamoleculeProgram 1 (Bristol Myers Squibb/PeptiDream)PD-L1 inhibitor millamolecule (Bristol Myers Squibb)
ClassificationBiologics
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A